The A-Sense Center of Excellence at Hamad Bin Khalifa University recently hosted a special lecture by Dr. Manish Arora, founder and CEO of Linus Biotechnology and a leading figure in exposomics.
Dr. Arora presented his pioneering research that led to the development of the world’s first biochemical test for autism, capable of identifying early risk in infants as young as one month old. His innovative hair exposomics platform, which uses robotics and laser-based analysis, captures millions of data points to trace environmental and biological influences over time.
In his talk, titled “An End-to-End Model with Linus Biotechnology: From Autism Diagnosis to Parent Training and Telehealth Support,” Dr. Arora explored how this breakthrough technology connects early diagnosis with parental training and telehealth solutions, creating a comprehensive model of care for families worldwide.
The event attracted researchers, clinicians, and students eager to learn about the latest advancements in early autism detection and the transformative potential of exposomics in personalized healthcare.
